SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending due to a new administration proposal suggesting near-flat Medicare Advantage payment rates for 2027, a significant reduction from industry expectations. This policy announcement has sparked intense community discussion about potential margin pressure and regulatory risk across the healthcare sector, with some investors seeing a buying opportunity amidst the volatility while others anticipate sustained headwinds.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is gaining significant traction as its fervent community rallies behind the 'OG meme' narrative, advocating for Rage Comics as the foundational 'meme reset' for the current crypto market. The dedicated base demonstrates strong conviction, actively developing an ecosystem with platforms like RageMaker and RageGames, while urging enthusiasts to 'Return to the Memes' and 'Rage On' to establish dominance in the sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is at the center of a frenzied market, experiencing extreme volatility and massive price swings as bullish investors and aggressive shorts clash. The community is buzzing over strong industrial demand, central bank buying, and alleged market manipulation, amplified by reports of institutional silver shorts and a significant premium in Asian markets. This dynamic is fueling intense debate, with many viewing current dips as buy opportunities while others anticipate a substantial pullback after its parabolic run.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a significant investment from Nvidia, which many view as a strong validation for its role in the rapidly expanding AI infrastructure sector. While some perceive this as a crucial strategic partnership to meet surging AI demand, others are cautious, questioning the company's profitability and suggesting the investment might be a bailout amidst high debt levels and insider selling. The community is actively debating whether this solidifies CoreWeave's future or underscores underlying financial concerns within the AI cloud space.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending amidst intense community frustration over its significant underperformance compared to Chinese tech peers, sparking widespread debate about potential price manipulation and management's perceived inaction. Despite its deep value metrics and recent share repurchases, investors are scrutinizing the effectiveness of its capital-intensive logistics network and aggressive food delivery expansion in a highly competitive market.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is actively discussed following recent pipeline expansion, notably the acquisition of VLX-1005 for heparin-induced thrombocytopenia, alongside ongoing manufacturing progress for its lead candidate, tecarfarin. While some investors emphasize its potential as a "warfarin replacement" and the impact of its ultra-low float, a strong segment of the community expresses skepticism due to cash burn concerns, past dilutions, and perceived bot activity fueling its trend.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing heightened discussion driven by market sentiment anticipating a potential capital rotation from recently surging precious metals like silver and gold. The community is actively debating its current price consolidation amidst strong belief in its 'digital gold' narrative and long-term scarcity.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending following an earnings report that surpassed revenue and EPS estimates, coupled with an updated outlook and dividend declaration. The company's significant workforce reductions and facility closures are generating widespread discussion as strategic moves to boost efficiency and focus on higher-margin logistics, even as community sentiment remains divided on the long-term implications for demand and profitability.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending amid significant market reaction to proposed flat Medicare Advantage payment rates and tighter billing rules for 2027, pressuring the broader healthcare insurance sector. Investors are discussing whether this policy shift will lead to prolonged margin compression or if CVS's diversified business model offers some resilience compared to more heavily impacted peers.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending following recent government proposals indicating nearly flat Medicare Advantage payment rates for the upcoming year, a significant shift from expected increases that is impacting the broader managed care sector. Community discussion centers on whether this regulatory move is an overreaction or a fundamental repricing of future growth and margin potential for insurers. This situation highlights rising policy risk for companies heavily reliant on Medicare Advantage as a core business.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last?

908 Devices (MASS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced...

908 Devices (NASDAQ:MASS) Stock Price Up 7.6% - What's Next?

908 Devices (NASDAQ:MASS) Trading 7.6% Higher - Still a Buy...

GM Advisory Group LLC Takes $8.31 Million Position in 908 Devices Inc. $MASS

GM Advisory Group LLC purchased a new position in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Mitsubishi UFJ Asset Management Co. Ltd. Purchases New Holdings in 908 Devices Inc. $MASS

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) in the second quarter, according to the company in its most recent 13F filing...

Leerink Partnrs Increases Earnings Estimates for 908 Devices

908 Devices Inc. (NASDAQ:MASS - Free Report) - Analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for 908 Devices in a research report issued on Monday, November 10th...

908 Devices (NASDAQ:MASS) Issues Quarterly Earnings Results

908 Devices (NASDAQ:MASS - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.03...

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices (MASS) delivered earnings and revenue surprises of -15.38% and +3.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported...

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Sight Sciences (SGHT) delivered earnings and revenue surprises of +38.46% and +15.98%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Burlington, MA.

908 Devices Inc

No change

25 bps cut

25 bps hike

Note sure, just watching

The Fed announces its rate decision this Wednesday.

Markets are pricing in a ~99% chance of no change at this week’s Fed decision, according to prediction markets. $SPY $QQQ 

FOMC on Wednesday, what do you think the Fed will decide?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.07	--	--	N/A
Q3 '25	-$0.14	-$0.04	71.87%	BEAT
Q2 '25	-$0.17	-$0.36	-111.76%	MISSED
Q1 '25	-$0.28	-$0.28	--	EXPECTED
Q4 '24	-$0.33	-$0.56	-68.04%	MISSED

MASS
908 Devices Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MASS News

MASS908 Devices Inc